JP2014525584A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525584A5 JP2014525584A5 JP2014528663A JP2014528663A JP2014525584A5 JP 2014525584 A5 JP2014525584 A5 JP 2014525584A5 JP 2014528663 A JP2014528663 A JP 2014528663A JP 2014528663 A JP2014528663 A JP 2014528663A JP 2014525584 A5 JP2014525584 A5 JP 2014525584A5
- Authority
- JP
- Japan
- Prior art keywords
- c12orf56
- sample
- cancer
- dscr8
- sbk1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000906689 Homo sapiens Uncharacterized protein C12orf56 Proteins 0.000 claims 16
- 102100023446 Uncharacterized protein C12orf56 Human genes 0.000 claims 16
- -1 COLl0A1 Proteins 0.000 claims 15
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 102100022142 Achaete-scute homolog 1 Human genes 0.000 claims 8
- 102100032484 Down syndrome critical region protein 8 Human genes 0.000 claims 8
- 101000901099 Homo sapiens Achaete-scute homolog 1 Proteins 0.000 claims 8
- 101001016533 Homo sapiens Down syndrome critical region protein 8 Proteins 0.000 claims 8
- 101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 claims 8
- 101000990912 Homo sapiens Matrilysin Proteins 0.000 claims 8
- 101000814371 Homo sapiens Protein Wnt-10a Proteins 0.000 claims 8
- 101000693598 Homo sapiens Serine/threonine-protein kinase SBK1 Proteins 0.000 claims 8
- 102100027998 Macrophage metalloelastase Human genes 0.000 claims 8
- 102100030417 Matrilysin Human genes 0.000 claims 8
- 102100039461 Protein Wnt-10a Human genes 0.000 claims 8
- 102100025554 Serine/threonine-protein kinase SBK1 Human genes 0.000 claims 8
- 102100036217 Collagen alpha-1(X) chain Human genes 0.000 claims 7
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 claims 7
- 101001120760 Homo sapiens Olfactomedin-4 Proteins 0.000 claims 7
- 101000577877 Homo sapiens Stromelysin-3 Proteins 0.000 claims 7
- 102100026071 Olfactomedin-4 Human genes 0.000 claims 7
- 108091006959 SLC35D3 Proteins 0.000 claims 7
- 102100032281 Solute carrier family 35 member D3 Human genes 0.000 claims 7
- 102100028847 Stromelysin-3 Human genes 0.000 claims 7
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 6
- 102100025471 Epiphycan Human genes 0.000 claims 6
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims 6
- 101001056751 Homo sapiens Epiphycan Proteins 0.000 claims 6
- 102100035671 Cadherin EGF LAG seven-pass G-type receptor 3 Human genes 0.000 claims 5
- 102100035911 Guanine nucleotide-binding protein G(T) subunit gamma-T1 Human genes 0.000 claims 5
- 101000715671 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 3 Proteins 0.000 claims 5
- 101001073279 Homo sapiens Guanine nucleotide-binding protein G(T) subunit gamma-T1 Proteins 0.000 claims 5
- 101000854595 Homo sapiens Protein FAM166C Proteins 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 102100020939 Protein FAM166C Human genes 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 102000053602 DNA Human genes 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 108091058560 IL8 Proteins 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161529500P | 2011-08-31 | 2011-08-31 | |
| US61/529,500 | 2011-08-31 | ||
| US201161542403P | 2011-10-03 | 2011-10-03 | |
| US61/542,403 | 2011-10-03 | ||
| PCT/US2012/053472 WO2013033609A2 (en) | 2011-08-31 | 2012-08-31 | Methods and compositions for the treatment and diagnosis of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014525584A JP2014525584A (ja) | 2014-09-29 |
| JP2014525584A5 true JP2014525584A5 (enExample) | 2015-10-29 |
Family
ID=47757190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014528663A Pending JP2014525584A (ja) | 2011-08-31 | 2012-08-31 | 癌の治療および診断のための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140206574A1 (enExample) |
| EP (1) | EP2751570A4 (enExample) |
| JP (1) | JP2014525584A (enExample) |
| KR (1) | KR20140057361A (enExample) |
| CN (1) | CN103890587A (enExample) |
| AU (1) | AU2012301664A1 (enExample) |
| CA (1) | CA2844793A1 (enExample) |
| HK (1) | HK1199099A1 (enExample) |
| WO (1) | WO2013033609A2 (enExample) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2294216A4 (en) | 2008-05-14 | 2011-11-23 | Dermtech Int | DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY ANALYSIS OF NUCLEIC ACIDS |
| US20150299799A1 (en) * | 2012-10-05 | 2015-10-22 | Michael Sturzl | Method for Detecting an Increased Risk or Incidence of Colorectal Cancer |
| EP2853596A1 (en) * | 2013-09-30 | 2015-04-01 | IKBT (Institut für Klinische Biomedizinische Forschung Thurgau) | Protein phosphatase inhibitor |
| GB201320061D0 (en) * | 2013-11-13 | 2013-12-25 | Electrophoretics Ltd | Materials nad methods for diagnosis and prognosis of liver cancer |
| EP2876442A1 (en) * | 2013-11-22 | 2015-05-27 | Institut de Cancérologie de l'Ouest | Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer |
| US20160326594A1 (en) * | 2013-12-30 | 2016-11-10 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer gene profiles and methods of using the same |
| WO2016179043A1 (en) | 2015-05-01 | 2016-11-10 | Dermtech, Inc. | Non-invasive skin collection system |
| US11578373B2 (en) | 2019-03-26 | 2023-02-14 | Dermtech, Inc. | Gene classifiers and uses thereof in skin cancers |
| EP3825411A1 (en) * | 2014-06-18 | 2021-05-26 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
| KR101779147B1 (ko) * | 2014-07-04 | 2017-09-20 | 연세대학교 산학협력단 | Kiaa1199를 이용한 췌장암의 진단 또는 치료용 조성물 |
| CN105675735B (zh) * | 2014-11-19 | 2018-07-17 | 上海市第六人民医院 | 乳腺癌诊断标记物组合、应用及其测定方法 |
| JP6551967B2 (ja) * | 2015-01-30 | 2019-07-31 | 国立大学法人山口大学 | 肝細胞がんの転移性再発リスクの予測方法 |
| WO2016143697A1 (ja) * | 2015-03-06 | 2016-09-15 | 国立大学法人名古屋大学 | Ｓｙｔ１３、ｓｙｔ８、ａｎｏｓ１発現量による胃癌腹膜播種の検査方法、検査キット、分子標的治療薬スクリーニング方法、及び治療薬 |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| CR20210232A (es) | 2015-03-17 | 2022-06-24 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVA COMBINACIÓN DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA CONTRA EL CÁNCER DE PÁNCREAS Y OTROS TIPOS DE CÁNCER (Divisional 2017-0419) |
| JP2016214239A (ja) * | 2015-05-15 | 2016-12-22 | 国立大学法人高知大学 | 膵がんマーカー |
| JP6659250B2 (ja) * | 2015-06-19 | 2020-03-04 | 国立大学法人滋賀医科大学 | 癌の検査方法、癌細胞増殖阻害剤、抗癌剤及び抗癌剤のスクリーニング方法 |
| CN105463070B (zh) * | 2015-07-08 | 2018-12-28 | 上海市同仁医院 | Uca1基因在制备诊断结直肠癌产品中的应用 |
| US10370647B2 (en) * | 2015-07-22 | 2019-08-06 | National University Corporation Tottori University | Host regulatory factor that enhances replication and/or propagation of vaccinia virus |
| CN108138239B (zh) * | 2015-07-24 | 2022-08-30 | 高丽大学校产学协力团 | 用于确定衰老、确定肥胖症和诊断癌症的生物标志物和使用其的诊断试剂盒 |
| US20170089905A1 (en) | 2015-09-28 | 2017-03-30 | Abbott Japan Co., Ltd. | Methods of diagnosing hepatocellular carcinoma and pancreatic cancer |
| KR20180118105A (ko) * | 2015-12-04 | 2018-10-30 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 면역치료를 위한 slc45a2 펩티드 |
| WO2017113565A1 (zh) * | 2015-12-29 | 2017-07-06 | 中国医学科学院肿瘤医院 | 基于蛋白标志物psg3辅助诊断肝癌或消化道癌症患者的试剂盒 |
| CN105504060B (zh) * | 2015-12-31 | 2018-10-26 | 陆梅生 | 一种抗胃癌细胞表面功能性表达的足萼样蛋白前体亚型2的单克隆抗体及其制备方法和用途 |
| US10294297B2 (en) | 2016-01-29 | 2019-05-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment using anti-NMU agents |
| CN106399306B (zh) * | 2016-04-12 | 2019-11-05 | 西安交通大学第一附属医院 | 靶向人lncRNA-UCA1抑制膀胱癌的sgRNA、基因载体及其应用 |
| SE540173C2 (en) * | 2016-04-20 | 2018-04-24 | Hiloprobe Ab | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor |
| CN106047874B (zh) * | 2016-06-02 | 2019-01-18 | 吉林大学 | 一种靶向sall4基因的脱氧核酶分子及在乳腺癌基因治疗中的应用 |
| US10927070B2 (en) | 2016-06-09 | 2021-02-23 | Cedars-Sinai Medical Center | Compositions and methods for treating cancer |
| CN108329387B (zh) * | 2017-01-17 | 2021-07-27 | 复旦大学附属肿瘤医院 | 癌症相关的肿瘤特异转录本lin28b-tst及其用途 |
| IL296349A (en) * | 2017-05-16 | 2022-11-01 | Univ Hong Kong Chinese | Integrative single-cell and cell-free plasma rna analysis |
| WO2018218737A1 (zh) * | 2017-06-01 | 2018-12-06 | 立森印迹诊断技术（无锡）有限公司 | 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统 |
| CN107312096B (zh) * | 2017-07-17 | 2019-12-20 | 湖北大学 | 用于检测组蛋白位点三甲基化修饰的重组蛋白及其应用 |
| CN107449916B (zh) * | 2017-07-27 | 2019-05-21 | 北京邦菲生物科技有限公司 | 肺癌和肺部结节蛋白特征谱及其构建方法与应用 |
| CN107807243B (zh) * | 2017-11-24 | 2020-08-07 | 暨南大学 | 一种食管癌的生物标志物及其应用 |
| CN108152496B (zh) * | 2017-11-24 | 2020-10-27 | 暨南大学 | Mest蛋白在制备肺癌辅助诊断和/或预后判断的试剂盒中的应用 |
| RU2760984C1 (ru) * | 2017-12-13 | 2021-12-02 | Иновио Фармасьютикалз, Инк. | Противораковые вакцины, направленные на lemd1, и их применение |
| US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
| GB201803750D0 (en) * | 2018-03-08 | 2018-04-25 | Immunocore Ltd | Method |
| AU2019276749A1 (en) * | 2018-05-29 | 2020-12-03 | Turun Yliopisto | L1TD1 as predictive biomarker of colon cancer |
| CN108796079B (zh) * | 2018-06-06 | 2021-07-27 | 天津医科大学肿瘤医院 | 一种逆转录转座基因l1-fggy及其作为肺鳞癌标志物的用途 |
| CN109116023B (zh) * | 2018-06-14 | 2021-06-04 | 郑州大学第一附属医院 | 一种肺癌标志物抗-mmp12自身抗体及其应用 |
| US11746387B2 (en) | 2018-06-20 | 2023-09-05 | Pontificia Universidad Catolica De Chile | Non-invasive detection of gastric cancer by detecting the methylation of Reprimo-like in the blood |
| WO2020017676A1 (ko) * | 2018-07-20 | 2020-01-23 | 주식회사 셀투인 | Fresh-트레이서 기반 분리된 세포의 유전자 프로파일의 응용 |
| CN109082473A (zh) * | 2018-10-16 | 2018-12-25 | 兰州大学 | 一种公牛znf280ay基因拷贝数变异的检测方法及应用 |
| CN112867495B (zh) | 2018-10-19 | 2024-08-20 | 韩国生命工学研究院 | 包含syt11抑制剂作为活性成分的胃癌治疗组合物 |
| JP7216995B2 (ja) * | 2018-12-05 | 2023-02-02 | 学校法人関西医科大学 | 胸腺癌バイオマーカー及び胸腺腫瘍の予後予測マーカー |
| CN109371023A (zh) * | 2018-12-11 | 2019-02-22 | 宁夏医科大学总医院 | 一种环状RNA hsa_circKIAA1199_006及其特异性扩增引物和应用 |
| CN114127114B (zh) * | 2019-04-30 | 2025-02-25 | Absci公司 | 癌相关抗体组合物和使用方法 |
| CN110218796B (zh) * | 2019-06-27 | 2020-01-17 | 江门市中心医院 | 用于乳腺癌骨转移诊疗的新靶标pcdhb2 |
| CN112147324A (zh) * | 2019-06-28 | 2020-12-29 | 欧蒙医学实验诊断股份公司 | 自身抗体的检测 |
| WO2021003246A1 (en) * | 2019-07-01 | 2021-01-07 | Accure Health Inc. | Predictive liquid markers for cancer immunotherapy |
| CN110796625B (zh) * | 2019-10-30 | 2023-06-20 | 重庆邮电大学 | 一种基于组稀疏表示和加权全变分的图像压缩感知重构方法 |
| CN111218509B (zh) * | 2019-12-23 | 2023-07-04 | 西南医科大学附属医院 | 乳腺癌的新诊断标志物ppef1及其应用 |
| WO2021231327A2 (en) * | 2020-05-12 | 2021-11-18 | Memorial Sloan Kettering Cancer Center | Methods for de-cloaking cancer from the immune system through downregulation of cancer-produced pregnancy specific glycoprotein |
| CN115851942A (zh) * | 2020-12-22 | 2023-03-28 | 上海市第一人民医院 | 诊断标志物gata4在胰腺“炎癌转化”中的应用 |
| CN115216542A (zh) * | 2021-04-15 | 2022-10-21 | 复旦大学附属华山医院 | 一组肿瘤筛查、鉴别的标志物及应用 |
| CN116087519B (zh) * | 2021-05-17 | 2025-03-14 | 郑州大学第一附属医院 | 一种用于高危人群贲门腺癌早期筛查的标志物及其应用 |
| CN113504370B (zh) * | 2021-06-29 | 2024-02-09 | 广州金研生物医药研究院有限公司 | Mapk15蛋白在前列腺癌的恶性程度或预后程度预测中的应用 |
| CN115537464B (zh) * | 2021-06-30 | 2023-06-20 | 武汉艾米森生命科技有限公司 | 一种结直肠癌或癌前病变的诊断或辅助诊断试剂、核酸组合、试剂盒及应用 |
| CN113980963B (zh) * | 2021-09-03 | 2024-05-28 | 中山大学 | 一种寡核苷酸rna双链分子及其在制备治疗恶性肿瘤药物中的应用 |
| CN114807369A (zh) * | 2021-11-15 | 2022-07-29 | 四川大学华西医院 | 一种与前列腺癌显著相关的潜在抗原、免疫分型及其构建方法和应用 |
| CN115992229B (zh) * | 2022-07-22 | 2023-07-07 | 中南大学湘雅三医院 | 一种胰腺癌预后风险评估的lncRNA标记物、模型及其应用 |
| CN117486999B (zh) * | 2022-08-30 | 2025-03-18 | 暨南大学 | 一种肿瘤T细胞抗原表位肽、pMHC及其制备和应用 |
| CN115838804A (zh) * | 2022-10-07 | 2023-03-24 | 厦门医学院 | 血浆外泌体lncRNAs作为靶标在急性髓系白血病诊断和疗效监测中的应用 |
| CN115786518A (zh) * | 2022-11-29 | 2023-03-14 | 广东医科大学附属医院 | 嗅素结构域家族蛋白4（olfm4）在结肠癌检测产品中的应用 |
| CN116482365B (zh) * | 2023-03-14 | 2023-10-20 | 南京芯原生物科技有限公司 | 用于检测血清抗体的蛋白组合物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004511527A (ja) * | 2000-10-18 | 2004-04-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| US7705120B2 (en) * | 2001-06-21 | 2010-04-27 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| EP1466016A2 (en) * | 2002-01-09 | 2004-10-13 | Riken Institute Of Physical And Chemical Research | Cancer profiles |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| WO2005039382A2 (en) * | 2003-06-24 | 2005-05-06 | Genomic Health | Prediction of likelihood of cancer recurrence |
| US20050208499A1 (en) * | 2004-02-04 | 2005-09-22 | Graff Jonathan M | Markers for diagnosing and treating breast and ovarian cancer |
| WO2006016110A1 (en) * | 2004-08-10 | 2006-02-16 | University College Cardiff Consultants Limited | Methods and kit for the prognosis of breast cancer |
| WO2006133399A1 (en) * | 2005-06-08 | 2006-12-14 | Hitachi Chemical Research Center, Inc. | METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |
| US20070218512A1 (en) * | 2006-02-28 | 2007-09-20 | Alex Strongin | Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management |
| DE102006024416A1 (de) * | 2006-05-24 | 2008-04-30 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Prädiktives Genexpressionsmuster für kolorektale Karzinome |
| EP2502628B1 (en) * | 2006-06-23 | 2016-12-14 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
| RU2473555C2 (ru) * | 2006-12-19 | 2013-01-27 | ДжинГоу, Инк. | Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных |
| AT504702A1 (de) * | 2006-12-22 | 2008-07-15 | Arc Austrian Res Centers Gmbh | Set von tumormarkern |
| US20100087330A1 (en) * | 2007-01-26 | 2010-04-08 | Brian Leyland-Jones | Breast cancer gene array |
| EP2048242A1 (de) * | 2007-10-08 | 2009-04-15 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Microarray für die Expressionsanalyse der zellulären Glykosylierungsmaschinerie |
| US20110160072A1 (en) * | 2007-10-23 | 2011-06-30 | Clinical Genomics Pty. Ltd. | Method of diagnosing neoplasms |
| CN102027373B (zh) * | 2008-05-14 | 2017-10-10 | 埃斯苏黎世公司 | 发现用于前列腺癌诊断和治疗之生物标志物和药物靶标的方法及其确立的生物标志物测定 |
| EP2295564A4 (en) * | 2008-05-21 | 2011-08-10 | Toray Industries | COMPOSITION AND METHOD FOR DETERMINING CREAM CANCER |
| JP5819728B2 (ja) * | 2008-10-20 | 2015-11-24 | ファーマテスト・サービシーズ・オサケユキテュアＰｈａｒｍａｔｅｓｔ Ｓｅｒｖｉｃｅｓ Ｏｙ | Ｎａｖ３の遺伝子異常および複数遺伝子の異常発現を含む方法および使用 |
| GB2512153B (en) * | 2008-11-17 | 2014-11-12 | Veracyte Inc | Methods and compositions of molecular profiling for disease diagnostics |
| KR20120034593A (ko) * | 2009-03-09 | 2012-04-12 | 유니버시티 오브 조지아 리서치 파운데이션 인코퍼레이티드 | 위암 진단용 단백질 마커의 동정 |
| BR112012002942A2 (pt) * | 2009-08-10 | 2015-10-13 | Epitherix Llc | indazóis como inibidores da trilha de sinalização de wnt/b-catenina e empregos terapêuticos destes. |
| MX2012009215A (es) * | 2010-02-23 | 2012-11-23 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
-
2012
- 2012-08-31 HK HK14112558.3A patent/HK1199099A1/xx unknown
- 2012-08-31 JP JP2014528663A patent/JP2014525584A/ja active Pending
- 2012-08-31 EP EP12827944.5A patent/EP2751570A4/en not_active Withdrawn
- 2012-08-31 CA CA2844793A patent/CA2844793A1/en not_active Abandoned
- 2012-08-31 KR KR1020147008058A patent/KR20140057361A/ko not_active Withdrawn
- 2012-08-31 WO PCT/US2012/053472 patent/WO2013033609A2/en not_active Ceased
- 2012-08-31 US US14/240,698 patent/US20140206574A1/en not_active Abandoned
- 2012-08-31 CN CN201280051957.8A patent/CN103890587A/zh active Pending
- 2012-08-31 AU AU2012301664A patent/AU2012301664A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525584A5 (enExample) | ||
| Ma et al. | Clinical application and detection techniques of liquid biopsy in gastric cancer | |
| Shi et al. | A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma | |
| Liu et al. | Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis | |
| CN113286883A (zh) | 使用rna分析以检测疾病的方法 | |
| JP2014144959A5 (enExample) | ||
| JP2014508298A5 (enExample) | ||
| Yee et al. | Extracellular vesicles as potential biomarkers for early detection and diagnosis of pancreatic cancer | |
| JP2011229532A5 (enExample) | ||
| Zhang et al. | Human cytomegalovirus detection in gastric cancer and its possible association with lymphatic metastasis | |
| JP2013505007A5 (enExample) | ||
| US9429575B2 (en) | DNA aptamer specifically binding to EN2 (engrailed-2) and use thereof | |
| CN110205378B (zh) | 一组脊柱结核血浆miRNA联合诊断标记物及其应用 | |
| JP2014533372A5 (enExample) | ||
| CN113838531A (zh) | 一种基于转录组数据和机器学习策略评估细胞衰老程度的方法 | |
| Zhang et al. | Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma | |
| Carvalho et al. | Emerging lab-on-a-chip approaches for liquid biopsy in lung cancer: Status in CTCs and ctDNA research and clinical validation | |
| US20150204882A1 (en) | Methionine metabolites predict aggressive cancer progression | |
| Mostufa et al. | Giant magnetoresistance based biosensors for cancer screening and detection | |
| US20240229157A1 (en) | Compositions comprising nullomers and methods of using the same for cancer detection and diagnosis | |
| CN107586839A (zh) | 循环肿瘤细胞多种标志物联合检测试剂盒及其应用 | |
| WO2014026157A2 (en) | Methionine metabolites predict aggressive cancer progression | |
| JP2012120540A5 (ja) | 遺伝子発現プロファイルによる胃癌の検出 | |
| CN102965427A (zh) | 女性生殖器癌症相关snp位点多重检测方法的建立 | |
| CN107177676A (zh) | 长链非编码rna nonhsat113026用于肾癌诊断分子标志物的用途 |